The Indian market is expected to trade rangebound. Here is a list of fifteen stocks that are likely to be in focus today.

Drug major Cipla has entered into an agreement to sell its entire stake in Biomab Holding to Biomab Brilliant for a consideration of $25,77...

The company’s improved performance over the last four quarters is a testimony to the fact that these changes are paying off.